Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates. | J Immunother Precis Oncol | 2024 | 39219997 | PubTator, text mining | PubMed |
| Repetitive Sequence Stability in Embryonic Stem Cells. | Int J Mol Sci | 2024 | 39201503 | PubTator, text mining | PubMed |
| A Systematic Review of the Prevalence of Germline BRCA mutations in North Asia Breast Cancer Patients. | Asian Pac J Cancer Prev | 2024 | 38918649 | PubTator, text mining | PubMed |
| All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency. | Sci Rep | 2024 | 38877099 | PubTator, text mining | PubMed |
| Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease. | Am J Hum Genet | 2024 | 38749429 | PubTator, text mining | PubMed |
| Splice modulators target PMS1 to reduce somatic expansion of the Huntington's disease-associated CAG repeat. | Nat Commun | 2024 | 38609352 | PubTator, text mining | PubMed |
| Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells. | Cancer Discov | 2024 | 38587317 | PubTator, text mining | PubMed |
| MutSβ-MutLβ-FANCJ axis mediates the restart of DNA replication after fork stalling at cotranscriptional G4/R-loops. | Sci Adv | 2024 | 38324687 | PubTator, text mining | PubMed |
| Recent Advances in Pyrimidine-Based Drugs. | Pharmaceuticals (Basel) | 2024 | 38256937 | PubTator, text mining | PubMed |
| Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications. | Int J Mol Sci | 2024 | 38256131 | PubTator, text mining | PubMed |
| Prognosis of Stage I Endometrial Cancer According to the FIGO 2023 Classification Taking into Account Molecular Changes. | Cancers (Basel) | 2024 | 38254879 | PubTator, text mining | PubMed |
| Glioblastoma vaccines: past, present, and opportunities. | EBioMedicine | 2024 | 38183840 | PubTator, text mining | PubMed |
| The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma. | Eur J Med Res | 2024 | 38178258 | PubTator, text mining | PubMed |
| Distinct patterns of proteostasis network gene expression are associated with different prognoses in melanoma patients. | Sci Rep | 2024 | 38167612 | PubTator, text mining | PubMed |
| ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma. | BMC Gastroenterol | 2024 | 38166741 | PubTator, text mining | PubMed |
| Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer. | Oncol Lett | 2024 | 38034487 | PubTator, text mining | PubMed |
| Rare single-nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome. | Cancer Rep (Hoboken) | 2024 | 37919876 | PubTator, text mining | PubMed |
| Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment. | Int J Mol Sci | 2023 | 38203325 | PubTator, text mining | PubMed |
| Plasma cell-free RNA profiling of Vietnamese Alzheimer's patients reveals a linkage with chronic inflammation and apoptosis: a pilot study. | Front Mol Neurosci | 2023 | 38178908 | PubTator, text mining | PubMed |
| DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair. | Pharmaceutics | 2023 | 38140100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=3